{"name": "Amadix",
 "permalink": "amadix",
 "crunchbase_url": "http://www.crunchbase.com/company/amadix",
 "homepage_url": "http://www.amadix.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "AmadixDx",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@amadix.com",
 "phone_number": "34-912-670-905",
 "description": "Innovative diagnostic tools",
 "created_at": "Mon Feb 11 03:09:47 UTC 2013",
 "updated_at": "Mon Feb 11 03:31:00 UTC 2013",
 "overview": "\u003Cp\u003EAmadix is a biotechnology Castilla y Le\u00f3n company focused on the development and commercialization of innovative diagnostic tools that support personalized treatment in the field of Oncology.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       102],
      "assets/images/resized/0023/4982/234982v1-max-150x150.jpg"],
     [[250,
       170],
      "assets/images/resized/0023/4982/234982v1-max-250x250.jpg"],
     [[450,
       307],
      "assets/images/resized/0023/4982/234982v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u20ac2M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2013/02/amadix-merges-transbiomed-raises-e2m-funding.html",
    "source_description": "Amadix Merges with Transbiomed and Raises \u20ac2M in Funding",
    "raised_amount": 2000000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2013,
    "funded_month": 2,
    "funded_day": 10,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "CRB Inverb\u00edo",
         "permalink": "crb-inverbo",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0023/4983/234983v1-max-150x150.jpg"],
             [[250,
               60],
              "assets/images/resized/0023/4983/234983v1-max-250x250.jpg"],
             [[295,
               71],
              "assets/images/resized/0023/4983/234983v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Inveready Capital Advisory",
         "permalink": "inveready-2",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0012/7001/127001v2-max-150x150.jpg"],
             [[250,
               71],
              "assets/images/resized/0012/7001/127001v2-max-250x250.jpg"],
             [[265,
               76],
              "assets/images/resized/0012/7001/127001v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "7 Alberto Aguilera St. ",
    "address2": "",
    "zip_code": "28015",
    "city": "Madrid ",
    "state_code": null,
    "country_code": "ESP",
    "latitude": 40.4297346,
    "longitude": -3.7080135}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}